Patient Names: Abiola and Adedayo
Ages: 15 & 13 years
Genders: Male
Country of Origin: Nigeria (currently residing in Ghana)
Condition: Autism
Treatment: Stem Cell Therapy
Treatment Duration: 2 Weeks
Hospital: StemRX, India
Treating Doctor: Dr. Pradeep Mahajan
Cost: 8,500 USD each
Overview
Abiola and his younger brother, Adedayo, are two boys aged 15 and 13, respectively. Though they share a strong bond as brothers, they also share the challenge of living with autism. Unlike many children with autism, Abiola and Adedayo are not hyperactive; they are calm and composed. However, they struggle with social interactions, often not responding when called, avoiding proactive play with others, and preferring to be alone.
Their parents, who reside in Ghana but are originally from Nigeria, became increasingly concerned about their sons' ability to integrate into society as they grew older. They knew finding the right treatment was essential for giving Abiola and Adedayo the best possible chance to lead more fulfilling lives.
Diagnosis and Decision
After exploring various treatment options, the family discovered stem cell therapy, which had shown promise in helping children with autism. During their research, they came across ClinicSpots, which serves as a bridge connecting patients with highly experienced doctors. And reached out through an online inquiry. The ClinicSpots team quickly connected them with Dr. Pradeep Mahajan at StemRX, a leading expert in stem cell therapy in India.
During the initial consultation, Dr. Mahajan reviewed the videos shared by the family and carefully explained the potential benefits of stem cell therapy, the treatment protocol, and the duration of the stay required in India. Understanding the financial and logistical challenges, the family decided to proceed with the treatment, taking six months to arrange the necessary funds for the procedure.
Treatment Journey
With the help of ClinicSpots, the family navigated the complex visa process. Since they were applying from Ghana as Nigerian nationals, a special request was sent to the embassy. ClinicSpots facilitated this process, and the visas were granted within a week, allowing the family to travel to India promptly.
ClinicSpots also arranged for the family’s pickup and drop-off at the airport and their accommodation near StemRX, ensuring a smooth and comfortable experience throughout their stay. The treatment, which lasted for two weeks, was conducted under the expert care of Dr. Pradeep Mahajan at StemRX.
The boys were accommodated in the same room to ensure their comfort, and the medical team followed a carefully tailored protocol to address their specific needs. While Dr. Mahajan set realistic expectations, especially given the boys’ ages, the family was hopeful about the potential improvements.
Recovery and Outcome
After completing the two-week treatment, Abiola and Adedayo returned to Ghana. The family is in the recovery phase, and regular follow-ups with Dr. Mahajan are planned to monitor the boys’ progress. While it is too early to determine the full extent of the treatment’s impact, the family remains optimistic.
Dr Mahajan has informed the family that while younger children often show more pronounced improvements with stem cell therapy, there is still potential for positive changes in Abiola and Adedayo’s social interactions and overall behaviour.
Reflections
The journey of Abiola and Adedayo highlights the power of hope, perseverance, and the advancements in medical treatment that can offer new possibilities for children with autism. The family’s experience with ClinicSpots has been one of support and care, from the initial inquiry to the completion of treatment. The seamless coordination of travel, accommodation, and medical care made a challenging journey more manageable.
As the family awaits further progress, their story inspires others facing similar challenges and underscores the importance of comprehensive support in ensuring that patients and their families receive the best possible care and outcomes.
Note: We respect our patient's privacy, so the name has been changed to maintain confidentiality.